Update on Category III CPT Code Application
Filed with ASX · · 1 page · English
Summary by 6ix AI
EchoIQ Limited has provided an update regarding its application for a Category III CPT code for EchoSolv AS in the US, following its presentation to the CPT Editorial Panel Meeting. The company has not yet received any indication of panel votes, which will be announced by the American Medical Association in the coming weeks. In the meantime, EchoIQ will continue its deployment of EchoSolv AS and pursue FDA clearance for EchoSolv HF, along with new product development and partnership opportunities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from EchoIQ
- Preliminary Final Report
- Quarterly Activities & Appendix 4C Cashflow Reports
- Reseller Agreement Secured with SARC MedIQ
- Mayo Clinic Validation Study Underway
- Echo IQ raises $17.3m via institutional placement
Later from EchoIQ
- Strong Operational Momentum
- Pause in Trading
- Trading Halt
- Category III CPT code application update
- Quarterly Activities and Appendix 4C Cash Flow Report
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ